Giuffre Randall Michael's Form 4 filing
DiaMedica Therapeutics Inc. (DMAC) · filed Dec 1, 2022
- Accession no.
- 0001235802-22-000128
- Filed
- Dec 1, 2022
- Trade date
- Nov 29-Dec 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $80.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Giuffre Randall MichaelCIK 0001759822 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2022 | Voting Common Shares, no par value per share | PPurchaseAcquired | +18,125 | $1.19 | +$21,568.75 | 128,350 | Direct | |
| Nov 30, 2022 | Voting Common Shares, no par value per share | PPurchaseAcquired | +2,970 | $1.19 | +$3,534.3 | 131,320 | Direct | |
| Dec 1, 2022 | Voting Common Shares, no par value per share | PPurchaseAcquired | +46,133 | $1.20 | +$55,359.6 | 177,453 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.